WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) received a stock award from SILO PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/30/2020ACC: 0001213900-20-010688
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+7.63M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.63M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.63M
Price / share
—
Trade value
—
% of position
2133.3%
4/17/2020
357.71K→7.99M
Total
Net shares
+7.63M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2020 | A · Award | +7.63M | — | — | 2133.3% | 357.71K | 7.99M |
| Total | +7.63M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported